Potential effects of digoxin on long-term renal and clinical outcomes in chronic heart failure

Journal of Cardiac Failure

Volumn 19, Issue 5, 2013, Pages 295-302

  Testani, Jeffrey M ^a   Brisco, Meredith A ^b   Tang, W H Wilson ^b   Kimmel, Stephen E ^b,c   Tiku Owens, Anjali ^b   Forfia, Paul R ^b   Coca, Steven G ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cardiorenal syndrome; digoxin; improved renal function; mortality

Indexed keywords

CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE; NITRATE; PLACEBO; POTASSIUM SPARING DIURETIC AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEATH; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HOSPITALIZATION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; TREATMENT OUTCOME; TREATMENT RESPONSE;

CARDIO-RENAL SYNDROME; CARDIOTONIC AGENTS; CREATININE; DIGOXIN; FEMALE; GLOMERULAR FILTRATION RATE; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED;

EID: 84879820175     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2013.03.002     Document Type: Article

References (19)

1. F.A. McAlister, J.A. Ezekowitz, L. Tarantini, I. Squire, M. Komajda, and A. Bayes-Genis Renal dysfunction in heart failure patients with preserved versus reduced ejection fraction: impact of the new CKD-EPI formula Circ Heart Fail 5 2012 309 314
2. K. Damman, G. Navis, A.A. Voors, F.W. Asselbergs, T.D. Smilde, and J.G. Cleland Worsening renal function and prognosis in heart failure: systematic review and meta-analysis J Card Fail 13 2007 599 608
3. J.M. Testani, B.D. McCauley, S.E. Kimmel, and R.P. Shannon Characteristics of patients with improvement or worsening in renal function during treatment of acute decompensated heart failure Am J Cardiol 106 2010 1763 1769
4. J.T. Heywood, G.C. Fonarow, M.R. Costanzo, V.S. Mathur, J.R. Wigneswaran, J. Wynne ADHERE Scientific Advisory Committee and Investigators High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database J Card Fail 13 2007 422 430
5. J.M. Testani, B.D. McCauley, J. Chen, S.G. Coca, T.P. Cappola, and S.E. Kimmel Clinical characteristics and outcomes of patients with improvement in renal function during the treatment of decompensated heart failure J Card Fail 17 2011 993 1000
6. C.M. O'Connor, R.C. Starling, A.F. Hernandez, P.W. Armstrong, K. Dickstein, and V. Hasselblad Effect of nesiritide in patients with acute decompensated heart failure N Engl J Med 365 2011 32 43
7. B.M. Massie, C.M. O'Connor, M. Metra, P. Ponikowski, J.R. Teerlink, and G. Cotter Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure N Engl J Med 363 2010 1419 1428
8. M. Gheorghiade, M.A. Konstam, J.C. Burnett, L. Grinfeld, A.P. Maggioni, and K. Swedberg Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST clinical status trials JAMA 297 2007 1332 1343
9. M. Gheorghiade, M.E. Harinstein, and G.S. Filippatos Digoxin for the treatment of chronic and acute heart failure syndromes Acute Card Care 11 2009 83 87
10. Digitalis Investigation Group Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: a large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure Control Clin Trials 17 1996 77 97
11. Digitalis Investigation Group The effect of digoxin on mortality and morbidity in patients with heart failure N Engl J Med 336 1997 525 533
12. A.S. Levey, J. Coresh, T. Greene, L.A. Stevens, Y.L. Zhang, and S. Hendriksen Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate Ann Intern Med 145 2006 247 254
13. J.M. Testani, B.D. McCauley, J. Chen, M. Shumski, and R.P. Shannon Worsening renal function defined as an absolute increase in serum creatinine is a biased metric for the study of cardio-renal interactions Cardiology 116 2010 206 212
14. S.S. Rathore, J.P. Curtis, Y. Wang, M.R. Bristow, and H.M. Krumholz Association of serum digoxin concentration and outcomes in patients with heart failure JAMA 289 2003 871 878
15. R.M. Mickey, and S. Greenland The impact of confounder selection criteria on effect estimation Am J Epidemiol 129 1989 125 137
16. M.G. Shlipak, G.L. Smith, S.S. Rathore, B.M. Massie, and H.M. Krumholz Renal function, digoxin therapy, and heart failure outcomes: evidence from the digoxin intervention group trial J Am Soc Nephrol 15 2004 2195 2203
17. M. Gheorghiade, D.J. van Veldhuisen, and W.S. Colucci Contemporary use of digoxin in the management of cardiovascular disorders Circulation 113 2006 2556 2564
18. G.E. Newton, J.H. Tong, A.M. Schofield, A.D. Baines, J.S. Floras, and J.D. Parker Digoxin reduces cardiac sympathetic activity in severe congestive heart failure J Am Coll Cardiol 28 1996 155 161
19. M. Gheorghiade, V.B. Hall, G. Jacobsen, M. Alam, H. Rosman, and S. Goldstein Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors Circulation 92 1995 1801 1807